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Background: Ca2+-dependent inactivation and 
facilitation of Cav2.1 Ca2+ channels are major
determinants of neuronal excitability and 
synaptic plasticity. 
Result: The Ca2+ -binding protein calretinin 
interacts with Cav2.1 and inhibits Ca2+-
dependent inactivation and enhances 
facilitation of Cav2.1.
Conclusion: In addition to its role as a 
diffusible Ca2+ buffer, calretinin can interact 
with targets such as Cav2.1 and modulate their 
function.
Significance: Calretinin-Cav2.1 interactions 
may shape Ca2+ signaling dynamics in 
neurons.
SUMMARY : 
Voltage-gated Cav2.1 Ca2+ channels 
undergo dual modulation by Ca2+, Ca2+-
dependent inactivation (CDI) and 
facilitation (CDF), which can influence 
synaptic plasticity in the nervous system. 
While the molecular determinants 
controlling CDI and CDF have been the 
focus of intense research, little is known 
about the factors regulating these processes 
in neurons. Here, we show that calretinin 
(CR), a Ca2+ binding protein highly 
expressed in subpopulations of neurons in 
the brain, inhibits CDI and enhances CDF 
by binding directly to D12.1. Screening of a 
phage display library with CR as bait 
revealed a highly basic CR-binding domain 
(CRB) present in multiple copies in the 
cytoplasmic linker between domains II and 
III of D12.1. In pull-down assays, CR 
binding to fusion proteins containing these 
CRBs was largely Ca2+-dependent. D12.1 
coimmunoprecipitated with CR antibodies 
from transfected cells and mouse 
cerebellum, which confirmed the existence 
of CR-Cav2.1 complexes in vitro and in vivo.
In HEK293T cells, CR significantly
decreased Cav2.1 CDI and increased CDF. 
CR binding to D12.1 was required for these 
effects, since they were not observed upon 
substitution of the II-III linker of D12.1 with 
that from the Cav1.2 D1 subunit (D11.2) 
which lacks the CRBs. In addition,
coexpression of a protein containing the 
CRBs blocked the modulatory action of 
CR, most likely by competing with CR for 














highlight an unexpected role for CR in 
directly modulating effectors such as
Cav2.1, which may have major 
consequences for Ca2+-signaling and
neuronal excitability.
Voltage- gated Cav2.1 channels 
mediate Ca2+ influx that triggers 
neurotransmitter release from presynaptic 
nerve terminals at most synapses in the central 
nervous system (1). Because the amount of 
neurotransmitter released is proportional to the 
third or fourth power of the presynaptic Ca2+
concentration (2,3), modulation of Cav2.1 
properties can greatly alter synaptic output and 
contribute to mechanisms of synaptic 
plasticity (4). 
Like other Cav channels, Cav2.1 
channels undergo a prominent feedback 
regulation by incoming Ca2+ ions, which 
depends on calmodulin (CaM) (5,6).
However, unlike other Cav channels, CaM 
binding to the cytoplasmic C-terminal domain 
of D12.1 mediates both a negative and positive 
regulation by incoming Ca2+ ions, Ca2+-
dependent inactivation (CDI) and facilitation 
(CDF) (7). Both CDI and CDF have been
described for presynaptic Cav2.1 channels at 
central synapses (8-10) and can cause short-
term depression and facilitation, respectively, 
of neurotransmitter release (11). 
Ca2+-dependent modulation of native 
Cav2.1 channels is heterogeneous in neurons 
(12), which can be due to alternative splicing 
of sequences encoding the D12.1 C-terminal 
domain (13,14) or differences in auxiliary 
CavE subunit expression (15). In addition, 
neuron-specific Ca2+ binding proteins related 
to CaM can influence the extent of Cav2.1 
CDF and CDI: CaBP1 inhibits CDF and 
enhances CDI (16), while VILIP-2 increases 
CDF and inhibits CDI (17). CaBP1 and 
VILIP-2 bind to the same sites as CaM in the 
C-terminal domain of D12.1, but structural 
differences from CaM underly their distinct 
modulation of Cav2.1 (17,18). 
Within the EF-hand superfamily of 
Ca2+ binding proteins, CaM, CaBP1, and 
VILIP-2 are considered Ca2+ sensors, so 
defined by their abilities to undergo Ca2+-
dependent conformational change and interact 
with effectors. In contrast, Ca2+ binding 
proteins such as parvalbumin and calbindin D-
28k generally act as diffusible Ca2+ buffers 
that modulate cytoplasmic Ca2+ signals (19).
Like Ca2+ chelation by EGTA (7),
parvalbumin and calbindin D-28k can 
significantly alter CDI of Cav2.1 channels in 
transfected HEK293T cells (20). However, as 
parvalbumin and calbindin D-28k were not 
reported to associate directly with D12.1, their 
actions on Cav2.1 CDI are likely to be indirect 
and due primarily to their actions as diffusible 
Ca2+ buffers (20). 
Calretinin (CR) is a EF-hand Ca2+-
binding protein that is highly expressed in 
cerebellar granule neurons where Cav2.1 
channels are also expressed (19,21,22). Like 
parvalbumin and calbindin D-28k, CR is 
considered mainly as a Ca2+ signal modulator
in neurons. Based on its Ca2+ chelating 
properties, CR can significantly shape the 
spatiotemporal properties of Ca2+ signals 
generated by plasma membrane and 
intracellular Ca2+ channels (23). Yet, CR 
undergoes large conformational changes upon 
binding to Ca2+ (24,25), which may mediate 
Ca2+-dependent interactions with integral 
membrane proteins (26). While investigating 
the potential targets of CR, we discovered a 
consensus CR-binding motif in D12.1. Ca2+-
dependent binding of CR to this region 
nullifies CDI and enhances CDF in transfected 
HEK293T cells, which suggests that local 
tethering of CR to D12.1 is required for 
channel modulation. Our findings provide the 
first evidence that CR can directly alter Ca2+
signaling through interactions with effectors, 
thus raising new possibilities for how CR may 
modulate neuronal and network excitability
(27,28).
EXPERIMENTAL PROCEDURES
cDNAs and molecular biology
The following Cav2.1 subunit cDNAs were 
used: D12.1 (rbA isoform (29)), E2A (30), and 
D2G (31). GST-D12.1 fusion proteins 











motifs were generated by PCR and subcloning 
of the corresponding sequence in EcoRI/XhoI
sites of pGEX-4T1 (GE Healthcare 
Biosciences, Piscataway, NJ). For the 
chimeric Ca2+ channel D12.1-1.2 subunit, 
amino acids 864 – 983 from rat brain D12.1 
were replaced by amino acids 807 – 923 of rat 
brain D11.2 (rbCII, (32)). The corresponding 
DNA sequence of D11.2 was amplified by 
PCR and cloned into AscI/SgrAI sites of the 
D12.1-containing expression plasmid. GFP-CR 
was generated by cloning a PCR fragment 
containing the cDNA coding for human CR 
(836 bp) in the plasmid pEGFP-C1 (Life 
Technologies, Grand Island, NY) using CR-
specific primers comprising EcoRI and BamHI
sites; the sequence of the insert was verified 
prior to use in experiments. For the expression 
construct containing the first 3 CRB motifs of 
D12.1 (mcherry-CRB1-3), the corresponding
sequence (aa 899-953) and Kozak sequence 
was amplified from rat brain D12.1 by PCR 
and subcloned into XhoI and HindIII
restriction sites of pEGFPN1-mcherry (a kind 
gift from S. England). All cDNA constructs 
were subject to sequencing prior to use in 
experiments.
Cell Culture and Transfection
HEK293 cells transformed with SV40 T-
antigen (HEK293T) were maintained in 
DMEM (Life Technologies, Grand Island, 
NY) with 10% fetal bovine serum at 37 °C in 
a humidified atmosphere with 5% CO2. Cells 
were grown to 70- 80% confluence and 
transfected with Gene Porter reagent 
(Genlantis, San Diego, CA) or Fugene 6 
(Promega, Fitchburg, WI) according to the 
manufacturer’s protocols. For 
electrophysiology, cells were plated in 35 mm 
dishes and transfected with Cav2.1 subunit
cDNAs: D12.1 (2 Pg), E2A (1 Pg), and D2G (1 
Pg). pEGFPN1 or GFP-CR was cotransfected 
(1 Pg), which facilitated identification of 
transfected cells by fluorescence. For pull-
down assays, cells were plated in 60 mm 
dishes and transfected with GFP-CR (6 ȝg). 
For coimmunoprecipitation experiments, cells 
were plated in 60 mm dishes and transfected 
with Cav2.1 subunits GFP-D12.1 (3.2 Pg), E2A
(1.6 Pg), and D2G (1.6 Pg) and pEGFPN1 (1.6 
Pg) or GFP-CR (1.6 Pg). 
Phage display and binding assays 
Purified human recombinant CR-coated 7.5 
cm2 plastic plates and the Ph.D.™-7 Phage 
Display Peptide Library Kit (New England 
Biolabs Inc, Biocencept, Allschwil, 
Switerzerland) were used according to the 
manufacturer’s protocol with 3 rounds of 
panning. The cDNA coding for the surface-
exposed heptapeptides (part of the pIII coat 
protein) was extracted from E.coli strain 
ER2738, amplified by PCR, and subject to 
DNA sequencing (Microsynth, GmbH, 
Balgach, Switzerland). 
GST-D12.1 fusion proteins containing 
one or more CR-binding (CRB) motifs were 
expressed in E. coli and purified on 
glutathione-Sepharose according to standard 
protocols. For experiments with fluorescently 
tagged purified CR, Alexa 488-labeled CR 
(CR*; 0-20 M) was incubated with GST -
D12.1 fusion proteins or GST control (10 M) 
in binding buffer (in mM: 140 K-glutamate, 2 
ATP, 1.25 MgCl2, 20 PIPES, 0.4 EGTA; pH 
7.2, adjusted with KOH). Ca2+-containing 
solutions included 1.6 mM CaCl2 (Ca2+free:
~300 M). Reactions were carried out at room 
temperature for 1 hour. Sample mixtures were 
applied to GST MultiTrap 4B (GE Healthcare) 
96-well filter plates pre-packed with 
Glutathione-Sepharose. Bound CR*/ GST-
D12.1 complexes were eluted with elution 
buffer (10 mM glutathione, 50 mM Tris-HCl, 
pH 8.0) and fluorescence was measured with a 
Victor X3 plate reader (Perkin Elmer,
Waltham, MA). 
For experiments with GFP-CR
expressed in HEK293T cells, transfected cells 
were harvested and homogenized in 1 ml of 
ice-cold cell lysis buffer (50 mM Tris-HCl, 
150 mM NaCl, 1% TritonX-100, 0.25% w/v 
sodium deoxycholate, 1 mM EDTA, pH 7.4 
and protease inhibitors) containing either 1.6 
mM CaCl2 or 1 mM EGTA. The homogenate 











membrane proteins and the insoluble material 
was separated by centrifugation at 16,100 x g
(30 min). The supernatant (300 ȝl) was 
incubated with 40 ȝl of a 50% slurry of 
immobilized GST-CRB1-3 brought to 1 ml 
with the lysis buffer at 4°C overnight. The 
beads were washed three times with 1 ml of 
ice cold lysis buffer and the bound proteins 
were eluted with SDS-containing sample 
buffer, subjected to SDS-PAGE, and 
transferred to nitrocellulose. Mouse 
monoclonal antibodies anti-GFP (1:3000, 
Santa Cruz Biotechnology, Santa Cruz, CA)
were used to detect bound GFP-CR by
western blot.
Coimmunoprecipitation 
For coimmunoprecipitation from transfected 
HEK293T cells, transfected cells were 
harvested 48 hours after transfection. Cell 
lysates were prepared as described in binding 
assays and incubated with 5 ȝg CR antibodies 
(Swant) and 40 ȝl protein A-Sepharose (50% 
slurry) overnight, rotating at 4°C. After three 
washes with 1 ml cell lysis buffer, proteins 
were eluted and analyzed by SDS-PAGE.
Coimmunoprecipitated proteins were detected 
by Western blotting with anti-Į12.1 antibodies 
(1:300, Alomone Labs, Jerusalem, Israel) and 
anti-GFP antibodies (1:3000, Santa Cruz
Biotechnology).
For coimmunoprecipitation from 
mouse brain, the cerebellum was homogenized 
in 1 ml 250STMDPS buffer (250 mM sucrose,
50 mM Tris-HCl, 5 mM MgCl2, 1 mM DTT, 
pH 7.4, and protease inhibitors). The nuclear 
fraction was removed by centrifugation at 800
x g for 15 min. The membrane fraction was
separated from the cytosolic fraction by 
ultracentrifugation at 100,000 x g for 1 h. The 
membrane pellet was solubilized in 1 ml of 
solubilization buffer [Tris-buffered saline 
(TBS; 50 mM Tris-HCl, 150 mM NaCl, pH 
7.5), 1% Triton X-100, and protease inhibitors] 
at 4°C for 30 min and insoluble material 
removed by ultracentrifugation at 100,000 x g
for 1 h. Either 5 ȝg of rabbit IgG (Life 
Technologies) or anti-CR antibodies (Swant,
Marly, Switzerland) were added to the 
solubilized membrane proteins along with 50 
ȝl of Protein A-Sepharose (50% slurry,
Sigma-Aldrich, St. Louis, MO). Reactions
were continued overnight with end-over-end 
rotation at 4°C. The resin was collected by 
centrifugation and rinsed three times with 1 ml 
of solubilization buffer. Bound proteins were 
eluted, resolved by 4-12% SDS-
polyacrylamide gel and western blotting with
anti-CR antibodies (1:5000, Swant) and anti-
Į12.1 antibodies as described above.  
Electrophysiology of transfected HEK293T 
cells 
Whole-cell patch-clamp recordings were
acquired 36-60 h post-transfection with a 
HEKA (Lambrecht/Pfalz, Germany) EPC-9
patch-clamp amplifier. External recording 
solution contained (in mM): 150 Tris, 1 
MgCl2, and 10 CaCl2 or BaCl2. Internal 
solution contained (in mM): 140 N-methyl-D-
glucamine, 10 HEPES, 2 MgCl2, 2 Mg-ATP, 
and 0.5 EGTA. The pH of both solutions was 
adjusted to 7.3 with methanesulfonic acid. 
Electrode resistances were 1-2 M: in the bath 
solution, and series resistance was~2-4 M:,
compensated 60- 80%.  Membrane potential 
was held at -60 mV prior to action potential 
waveform protocols or to -80 mV prior to all 
other experiments. Acquired data was 
analyzed using Igor Pro software 
(Wavemetrics) and statistics were performed 
using SigmaPlot (Systat Software). All 
averaged data are presented as the mean ± 
SEM. In the figures, numbers of cells (n) are 
indicated in parentheses.
RESULTS
CR interacts with Cav2.1
While screening a heptapeptide phage display 
library for CR-interacting proteins, we 
identified a consensus CR-binding sequence, 
H(R/K)HRRR(E/D), consisting of 5-6 basic 
residues (His/Arg) flanked by an acidic 
(Glu/Asp) residue (Fig.1A). Bioinformatic 
analysis revealed that this CR-binding (CRB) 
sequence was repeated 5 times in the 
cytoplasmic loop between domains 2 and 3 of 
D12.1 (Fig.1B). The CRBs are C-terminal to 











(“synprint”; (33) and are highly conserved in 
D12.1 between species. The CRB-containing 
region is also present in the Cav2.2 D1 subunit 
(D12.2, Supplementary Fig.1), but absent in 
Cav1 D1 subunits. To test if the CRB(s)
directly interact with CR, pull-down assays 
were performed with GST-fusion proteins 
containing the first 3 CRBs in D12.1 (GST-
CRB1-3). CR bound to GST-CRB1-3, but not 
to control GST, in the presence of Ca2+ (1.6 
mM). Binding of CR was Ca2+-dependent 
since it was prevented when free Ca2+ was 
chelated with EGTA (1 mM, Fig.1C). To 
estimate the affinity of CR binding to D12.1, 
GST-CRB1-3 was incubated with varying 
amounts of fluorescently tagged CR. Binding 
was relatively low-affinity (EC50~10 M) and 
was stronger with than without Ca2+ (Fig.1D). 
Compared to CR binding to a GST-fusion 
protein containing only the most N-terminal 
CRB (CRB1), CR binding in the linear range 
of the binding curve was increased by 19.6 ± 
7.9% and 32.6 ± 13.6% for GST-proteins 
containing 2 (CRB 1,2) and 3 (CRB1-3) 
motifs, respectively (data not shown). These 
results confirm that CR binds in a Ca2+-
dependent manner to the CRBs in D12.1. 
If CR is an interacting partner of 
Cav2.1, it should also associate with the intact 
channel. To test this prediction, we 
coexpressed CR and Cav2.1 in HEK293T cells 
and used CR antibodies in 
coimmunoprecipitation experiments. CR 
antibodies brought down D12.1 in cells 
cotransfected with Cav2.1+ CR. Some D12.1
was brought down non-specifically by CR 
antibodies since a small amount of D12.1 was 
detected in immunoprecipitations from cells 
transfected with Cav2.1 alone (Fig.1E). 
However, a larger signal corresponding to 
D12.1 was consistently detected when Cav2.1 
was coexpressed with CR, indicating some 
specific association of CR with D12.1. To 
verify these results in the native context, we 
performed coimmunoprecipitation 
experiments with extracts from mouse 
cerebellum given that CR and Cav2.1 are both 
expressed highly in cerebellar granule neurons 
(19,21,22). In these experiments, CR 
antibodies but not control IgG 
coimmunoprecipitated D12.1 (Fig.1F). 
Together, these results demonstrate that CR 
associates with recombinant and native Cav2.1 
channels in the brain.
CR modulates CDI and CDF of Cav2.1 
To investigate the functional 
consequences of CR interacting with D12.1,
we compared the properties of Cav2.1
transfected alone or cotransfected with CR in 
HEK293T cells. Because Cav2.1 channels are 
strongly modulated by Ca2+, we analyzed both 
Ca2+ and Ba2+ currents (ICa and IBa,
respectively). In initial experiments, we found 
that CR had no significant impact on ICa or IBa
current density or on voltage-dependent 
activation of IBa, although it caused a modest 
positive shift in the current-voltage (I-V) 
relation for ICa (V1/2 = 2.7 mV±0.7 mV for 
Cav2.1 alone vs. 7.3±0.4 mV for Cav2.1+CR,
p<0.001; k= -5.4 ±0.2 for Cav2.1 alone vs. -
4.8±0.1 for Cav2.1+CR, p=0.03, both by t-test; 
Fig.2A,B).  
Ca2+-dependent binding of CR to the 
channel could dynamically alter Ca2+-
dependent modulation of Cav2.1. Due to a 
reliance on global elevations in Ca2+, CDI can 
be suppressed Ca2+ buffers such as EGTA (5-
10 mM). In contrast, CDF, which depends on 
rapid, local Ca2+ elevations, is not blunted by
high concentrations of EGTA (6,7). If CR 
acted as a Ca2+ buffer when bound to the 
channel, it could suppress CDI of Cav2.1. To 
test this, we performed experiments dissecting 
voltage- from Ca2+-dependent inactivation 
(VDI and CDI, respectively). Voltage 
protocols consisted of 2 test pulses (P1, P2) 
separated by a conditioning prepulse (Pre) to 
varying voltages (Fig.3A). With both Ca2+ and 
Ba2+ as the charge carrier, the second test 
current is smaller than the first due to
inactivation induced by the prepulse. The ratio 
of the P2:P1 test current amplitudes can 
therefore be used as a metric for inactivation
(Fig.3B). For Cav2.1, ICa, inactivation is 
significantly stronger than for IBa (P2/P1=0.31 
±0.07 for ICa vs. 0.68±0.04 for IBa, p<0.001).
In addition, the P2:P1 ratio exhibits U-shaped 











minimum at the prepulse voltage evoking the 
maximal inward ICa (Fig.3B). In contrast, IBa
shows a more modest and monotic increase in 
inactivation with prepulse voltage due to VDI 
(Fig.3A,B). Since Cav2.1 current density 
positively affects CDI (14,20), we restricted 
analysis to cells exhibiting maximal current 
densities between 13 and 19 pA/pF.  
Compared to the strong CDI in cells 
transfected with Cav2.1 alone, CDI was 
virtually undetectable across the full range of 
prepulse voltages in cells co-transfected with 
CR (Fig.3A-B). At prepulse voltages between 
-20 and +10 mV, ICa actually underwent 
facilitation (P2/P1>1). Facilitation was Ca2+-
dependent in that there was no effect of CR on 
inactivation of IBa (Fig.3C). Consistent with 
protocols that induce CDF (6), a prepulse to 0 
mV induced a significant acceleration in
activation kinetics of the P2 compared to the 
P1 current for both Cav2.1 alone (WP1=6 ± 1.3 
ms vs. WP2=2 ± 0.3 ms, n=6, p=0.02) and 
Cav2.1+CR (WP1=12.4 ± 1 ms, vs. WP2=1.9 ± 0.2 
ms, n=9, p<0.001). However, the prepulse-
induced speeding of the P2 activation kinetics 
was significantly greater for cells 
cotransfected with CR compared to Cav2.1 
alone (~125%, p=0.001).  To quantitate the 
Ca2+-dependent modulation seen with a 0-mV 
prepulse, the P2/P1 ratio of IBa was subtracted 
from that for ICa. This analysis clearly 
indicated that unlike Cav2.1 alone, which 
shows significant CDI, CR caused overt CDF 
(Fig.3C).  
We further analyzed the effects of CR 
on Cav2.1 CDF using action potential (AP) 
waveforms. During a train of 200-Hz AP 
stimuli, CDF is evident as a progressive 
increase in the amplitude of ICa; IBa undergoes 
less facilitation, which is voltage-dependent 
(Fig.4A,B). Consistent with our data obtained 
with conditioning prepulses (Fig.3), CR 
caused a significantly larger increase in ICa but 
not IBa by the end of the train (Fig.4C). We 
measured CDF as the difference in the 
amplitude of ICa and IBa at the end (0.5 s) of 
the train. By this metric, CDF for Cav2.1 was 
significantly greater with CR (0.22± 0.01,
n=10) than without (0.13± 0.03, n=8; p<0.01, 
t-test). These results confirm that CR enhances 
CDF of Cav2.1. 
These effects of CR on Cav2.1 CDI and 
CDF could be due to its actions as a freely 
diffusible Ca2+ buffer. Alternatively, CR 
binding to the D12.1 II-III linker may directly
suppress CDI and enhances CDF. To 
distinguish between these possibilities, we 
took advantage of the fact that the CRBs 
present in D12.1 are not conserved in the
Cav1.2 D1 subunit (D11.2). If CR binding to 
D12.1 is necessary for Cav2.1 modulation, then 
chimeric channels in which the 2-3 linker of 
D11.2 is substituted for that in D12.1 (Cav2.1-
1.2), should prevent effects of CR on CDI and 
CDF. Consistent with this prediction, Cav2.1-
1.2 channels underwent CDI that was not 
affected by CR (Fig.5A-C). In addition, there 
was no significant difference in CDF during 
AP trains in cells transfected with Cav2.1-1.2 
alone and cells cotransfected with CR 
(p=0.57; Fig.6). These results show that the 
CRBs are required for CR modulation of 
Cav2.1 CDI and CDF.
To verify the importance of CR 
binding to the CRBs for Cav2.1 modulation, 
we tested the impact of a peptide which should
competitively displace CR from binding sites 
in the D12.1 II-III linker. Since our 
biochemical experiments indicated that CR 
binds to a peptide sequence including the first 
3 CRBs (Fig.1), we generated a mcherry-
tagged peptide containing this region (CRB1-
3). Because CR had no effect on IBa either in 
inactivation or facilitation protocols (Fig.3,4), 
we restricted analysis to ICa and assumed 
effects on ICa inactivation and facilitation 
reflected effects on CDI and CDF, 
respectively. When cotransfected with 
Cav2.1+CR, CRB1-3 significantly opposed the 
decrease in CDI caused by CR (for a 0-mV 
prepulse, P2/P1=1.0±0.05 for Cav2.1+CR vs. 
0.58±0.11 for +CR+CRB1-3; p<0.01; Fig.7A).
Coexpression of CRB1-3 also significantly 
inhibited the effect of CR on CDF by the end 
of a 1-s AP train (p<0.05; Fig.7B). In contrast, 
there was no difference in CDI (p=0.43 for a 
0-mV prepulse) or CDF (p=0.93 at the end of 











alone and those cotransfected with 
Cav2.1+CRB1-3 (Fig.7C,D), which argued 
against non-specific inhibitory effects of 
CRB1-3 on Cav2.1 that were independent of 
CR modulation. Taken together, our results 
support a mechanism in which CR binding to 
the D12.1 II-III linker directly inhibits Cav2.1 
CDI and enables enhanced CDF of Cav2.1 
during repetitive stimuli.  
DISCUSSION
Our study provides key evidence for a new 
role for CR as an integral component of 
Cav2.1 complexes that modulates Cav2.1 
function. First, CR binds in a Ca2+-dependent 
manner to basic motifs in the D12.1 II-III 
linker. Second, CR forms a complex with 
Cav2.1 channels in the brain. Third, the
interaction of CR with the D12.1 II-III linker 
inhibits CDI and enhances CDF of Cav2.1 
channels and enhances CDF in transfected 
HEK293T cells. Because of the cellular 
overlap in CR and Cav2.1 expression in the 
brain (22,34), CR interactions with Cav2.1 
should be considered in models of how this 
protein controls Ca2+ signaling and excitability 
in neurons.
Ca2+ dependent binding of CR to effectors
CR has long been considered a diffusible Ca2+
buffer which can alter spatiotemporal aspects 
of Ca2+ signaling (19,23). However, multiple 
lines of evidence suggest that CR may not be 
freely diffusible and may in fact, interact with 
proteins in a manner analogous to “Ca2+
sensors” such as CaM. First, CR undergoes 
large conformational changes upon binding to 
Ca2+ (24,25). Similar Ca2+-dependent 
structural changes have been reported for the 
related EF-hand proteins, calbindin D28k and 
secretagogin (35,36). As in CaM, Ca2+ binding 
to CR may expose hydrophobic regions of the 
protein, which allow Ca2+-dependent 
interactions with other proteins. Second, in 
addition to its cytosolic localization, CR is 
also abundant in the membrane fraction of 
cerebellar extracts and less so under 
conditions of low Ca2+ (26). These latter 
findings could be explained by Ca2+-
dependent interactions of CR with integral 
membrane or membrane-associated proteins, 
much like the well-established role of CaM in 
regulating pre- and post-synaptic effectors 
(37).
Although our in vitro experiments 
indicate a relatively low binding affinity (~10 
PM) of CR for the D12.1 CRB sequences in 
GST-CRB1-3 (Fig.1D), we believe this may 
underestimate the ability of CR to interact 
with D12.1 in vivo. Because we found greater 
CR binding to GST proteins containing 3 
compared to 2 or 1 CRB sequences, it is likely 
that the 5 CRBs in the intact channel may 
increase the avidity of CR binding. In 
addition, CR is thought to be expressed at 
rather high concentrations in some neurons, 
ranging from approximately 40-80 M 
(27,38). These concentrations of CR would be 
sufficient to saturate the CRB sequence(s) in 
D12.1 to a large extent, particularly if the 
affinity between CR and CRBs is even higher 
within the intact channel complex than in 
vitro.While our biochemical analyses cannot 
allow conclusions regarding the stoichiometry 
of CR binding to the D12.1 II-III linker,
binding of CR to the GST-CRB1-3 protein 
was cooperative (Fig.1D). Since GST-CRB1-3
contains 3 of the 5 CRB sequences in the 
D12.1 II-III linker, it is possible that 
cooperativity in the binding assay resulted 
from multiple CR molecules binding to GST-
CRB1-3. Alternatively, many EF-hand 
proteins including CR isoforms show 
reversible dimerization in vitro (39). The 
binding of CR dimers to the CRBs could 
therefore also lead to the apparent 
cooperativity in binding to GST-CRB1-3.
Additional studies will be required to fully 
resolve the molecular thermodynamic 
properties of CR interactions with D12.1.
While our findings that CR
coimmunoprecipitates with Cav2.1 channels in 
the brain (Fig.1F) clearly implicate Cav2.1 as a 
CR target, it is important to note that basic 
amino acid sequences similar to the D12.1 
CRBs are likely present in other effectors. In 
particular, the CRBs are conserved in the
“synprint” region of the Cav2.2 D1 subunit 











not undergo CDF (40), synaptic protein 
interactions with the II-III linker of D12.2 
regulate voltage-dependent inactivation of 
Cav2.2 and inhibition of these channels by 
heterotrimeric G-proteins (41). Thus, it is 
possible that CR binding to the CRBs in D12.2 
could have important consequences for the 
modulation of Cav2.2 channels in neurons. 
The characterization of other CR-interacting 
proteins other than Cav2.1, and how they may 
be modulated by CR, is crucial for fully 
understanding Ca2+ signaling dynamics in the 
neuronal and non-neuronal cell-types in which 
CR is expressed (42,43). 
Cav2.1 CDI/CDF modulation by CR  
Significant progress has been made in 
elucidating the mechanisms underlying Cav2.1 
CDI and CDF (see (44) for review). CDI 
depends on the N-terminal lobe of CaM,
which responds to global rather than local 
Ca2+ signals. CDF depends on the C-lobe of 
CaM, which likely binds local Ca2+ ions as 
they emerge from the channel pore (6,45). In 
support of this model, intracellular dialysis 
with EGTA (10 mM) prevents CDI but not 
CDF (7). Moreover, CDF but not CDI is 
observed at the single channel level (46). This 
latter result and the findings that CDI 
increases with Cav2.1 current density (14,20)
illustrate that CDI depends on Ca2+ influx 
through multiple open channels and so should 
be sensitive to Ca2+ buffering. Based on the 
ability of CR to rapidly depress presynaptic 
Ca2+ signals (47), it is assumed that CR will 
act as a Ca2+ buffer when faced with a rise in 
intracellular Ca2+. Therefore, it is perhaps not 
surprising that coexpression of CR with 
Cav2.1 inhibited CDI. The remarkable result is
that CR accomplishes this through its 
association with the D12.1 II-III linker (Figs. 
6,7). Our biochemical and 
electrophysiological experiments show that 
disabling CR interactions with the D12.1 II-III 
linker prevents the channel modulation. The 
tethered CR may rapidly suppress global Ca2+
elevations that support CDI, which 
subsequently enhances CDF during trains of 
AP waveforms (Figs.3,4). Alternatively, CR 
binding to the II-III linker could allosterically 
modulate CDI in the manner of a Ca2+ sensor. 
Despite the presence of molecular 
determinants for CDI and CDF in the C-
terminal domain of Cav D1 subunits, auxiliary 
CavE subunit interactions with the I-II linker 
have been shown to modulate CDI and CDF 
of Cav1.2 channels (48). Experimental 
dissection of a Ca2+ buffering vs. Ca2+ sensor
mechanism is complicated by the possibility 
that disrupting the Ca2+ buffering activity of 
CR might also negate its ability to interact 
with the channel, but nevertheless is an 
important goal for future studies.
It is noteworthy that the CRBs in the 
D12.1 II-III linker overlap with the bipartite 
synprint site in D12.1. Interactions between 
SNAREs and the synprint are thought to 
promote efficient coupling of Cav2 channels 
and exocytosis in presynaptic nerve terminals 
based on evidence that peptides containing the 
synprint site impair neurotransmission (49,50).
Our findings suggest that such peptides may 
also influence CR regulation of Cav2.1 CDI 
and CDF and so may affect synaptic 
transmission via multiple mechanisms. In 
addition, splice variants lacking portions of 
the CRB/synprint region have been identified 
in neuroendocrine cells and various brain 
regions (51). The inability of CR to modulate 
CDI/CDF of such variants may further 
diversify Cav2.1 Ca2+ signaling between 
neuronal sub-types.
Neurophysiological significance of CR/Cav2.1
Immunohistochemical analyses indicate a 
number of neuronal cell groups in which CR 
and Cav2.1 colocalize. Cav2.1 channels are the 
major presynaptic Ca2+ channels in the nerve 
terminals forming the Calyx of Held synapse 
in the auditory brainstem (9,52). CR is 
detected presynaptically at these synapses but 
only at significant levels (>18% in rats) after 
postnatal day 14 (53). Electrophysiological 
recordings at the Calyx of Held synapse, 
usually done in brainstem slices from juvenile 
rats (postnatal day 8-10), indicate that the 
presynaptic Cav2.1 channels undergo CDI and 
CDF (8-10,54). Given our findings that CR 
inhibits CDI and enhances CDF, the 











expected to promote activity-dependent Ca2+
influx that may limit synaptic depression 
and/or increase reliability in the mature Calyx 
of Held synapse(55).  
As our coimmunoprecipitation of 
Cav2.1 with CR from mouse cerebellum 
would indicate, CR/Cav2.1 complexes may 
play a role in cerebellar granule cells, the 
predominant cell-types expressing CR in the 
cerebellum (56,57). Granule cells provide the 
major excitatory drive to Purkinje neurons in 
the form of parallel fibers. Genetic 
inactivation of CR in mice increases the 
intrinsic excitability of granule cells and 
Purkinje cell firing rate in vivo (27,28,58).
With respect to Cav2.1 in granule cells, loss of 
CR should inhibit Cav2.1 Ca2+ influx by 
enhancing CDI (Fig.3). Decreased ICa may
seem at odds with the hyperexcitable 
phenotype of CR-/- granule cells, since it 
would be expected to limit activation of Ca2+-
activated BK channels and subsequently, 
oppose repolarization following an action 
potential. However, we have observed 
compensatory changes in Cav2.1 subunit 
expression in cerebellar Purkinje neurons from 
mice lacking parvalbumin and calbindin (15),
which could also explain the lack of 
correlation between our findings and that 
expected in CR-/- granule cells. In addition, 
Cav2.1/CR interactions may be more relevant 
presynaptically, where enhanced CDF may 
support residual Ca2+ in parallel fiber 
terminals that causes short-term synaptic 
plasticity at the parallel fiber-Purkinje cell 
synapse (59).
In summary, our results implicate CR 
as a novel modulator of Cav2.1 channels, 
which may foreshadow yet additional roles for 
CR in actively regulating neuronal excitability 
and synaptic transmission through direct Ca2+-
dependent interactions with other effectors. 
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FIGURE LEGENDS
Figure 1. CR binds to D12.1. (A) Top, Schematic of calretinin (CR) with functional (EF1-5, white) 
and non-functional (EF6, grey) Ca2+-binding domains indicated. Bottom, consensus sequence for CR 
binding. (B) Schematic of Cav2.1 subunit, D12.1, with CR-binding domains (CRBs) in the II-III 
linker indicated (bold, underlined). Italics mark the synprint region. The sequence present in the 
GST-D12.1 fusion protein used for binding assays is shaded grey. (C) Pull-down assay of GFP-CR 
and GST-CRB1-3. GST (lanes 3,6) or GST-CRB1-3 (lanes 2,4) were immobilized on glutathione 
agarose beads and incubated with GFP-CR transfected HEK293T cell lysate in the presence of 1.6 











with GFP antibody. Bottom, Integrity and levels of GST-fusion proteins were shown by Ponceau S 
staining. (D) In vitro assay for CR binding to GST- CRB1-3. GST or GST-CRB1-3 was tested for 
binding to Alexa 488-labeled CR in the absence (-) or presence (+) of Ca2+ (~300 M). Fluorescence 
values were normalized to that obtained with 20 M CR in the presence of Ca2+ (% Maximal 
binding). Data are from 3 independent experiments done in duplicate. (E) Coimmunoprecipitation of 
Cav2.1 and CR from HEK293T cells. Cells transfected with Cav2.1 subunits alone or cotransfected 
with GFP-CR were subject to lysis and immunoprecipitation with rabbit CR antibodies. 
Immunoprecipitated proteins were detected by Western blotting with D12.1 (top) or GFP (bottom) 
antibodies. (F) Coimmunprecipitation of Cav2.1 and CR from mouse cerebellum. Mouse cerebellum 
lysates were incubated with rabbit antibodies against CR or control rabbit IgG. Immunoprecipitated 
proteins were detected by Western blotting with D12.1 (top) or calretinin (bottom) antibodies. Results 
shown in C and F are representative of 3 independent experiments; E is representative of 2 
independent experiments. 
Figure 2: CR modestly inhibits voltage-dependent activation of Cav2.1 ICa. Voltage protocol for 
current-voltage (I-V) relations and representative ICa (A) and IBa (B) current traces are shown for 
cells transfected with Cav2.1 alone or cotransfected with CR (+CR) with I-V curves shown below.
Figure 3: CR inhibits CDI and enhances Cav2.1 CDF. (A) Voltage protocol and representative 
traces for ICa and IBa are shown. P1 (black) and P2 (grey) test currents are overlayed for comparison. 
(B) The ratio of the amplitude of the P2 and P1 current (P2/P1) was plotted against prepulse voltage 
for ICa and IBa for cells transfected with Cav2.1 alone or Cav2.1+CR.  (C) Left, P2/P1 obtained with 0-
mV prepulse voltage for Cav2.1 and Cav2.1+CR. #, p<0.001 compared to ICa; *p<0.001 by t-test.
Right, CDI or CDF obtained with 0-mV prepulse represents P2/P1 ratio for ICa minus the mean 
P2/P1 ratio for IBa. *p<0.001, t-test.
Figure 4: CR enhances Cav2.1 CDF during AP trains. (A) AP waveform and representative ICa
evoked by 200-Hz train. Dashed line indicates initial current amplitude. Representative traces from 
the first (black) and 100th (grey) AP were overlaid for comparison for ICa and IBa in cells transfected 
with Cav2.1 alone or Cav2.1+CR. (B) Fractional current represents test current amplitudes 
normalized to the first in the train and plotted against time. (C) The maximal fractional current at 0.5 
s was compared for ICa and IBa. #p<0.001 compared to ICa; *p <0.03 by t-test.  
Figure 5: Cav2.1 channels lacking the CRBs are insensitive to CR modulation of CDI. (A-C) 
Same as in Fig. 3 except for Cav2.1-1.2 alone and Cav2.1-1.2+CR.  
Figure 6: Cav2.1 channels lacking the CRBs are insensitive to CR modulation of CDF. (A,B) 
Same as in Fig.4A,B except for Cav2.1-1.2 alone and Cav2.1-1.2+CR. (C) CDF shown for wild-type 
Cav2.1 or Cav2.1-1.2 ± CR. *p<0.005.   
Figure 7: A CR- binding peptide prevents effect of CR on Cav2.1 CDI and CDF. Same as 
Fig.3A,B and 4A,B but for ICa only and for cells transfected with Cav2.1+CR or +CR+CRB1-3 (A,B)
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